Results 101 to 110 of about 9,346,677 (199)

Nocebo and the potential harm of 'high risk' labelling:a scoping review

, 2015
AIMS: A discussion of the existence, prevalence and characteristics of the nocebo effect in health care.BACKGROUND: There is increasing but inconsistent evidence for nocebo effects (the opposite of placebo).
Adelasoye, Qadir A, Symon, Andrew, Williams, Brian, Cheyne, Helen, Adelasoye, Qadir A.   +4 more
core   +1 more source

Switching Patients from Originator to Biosimilar Medications in Rheumatoid Arthritis: Limiting the ‘Nocebo’ Effect

, 2017
Biosimilars have been available in Europe since 2006, and biosimilars of monoclonal antibodies since 2013, and are now a widespread clinical reality.
Biogen
core  

The Influence of Side Effect Information Framing on Nocebo Effects

, 2018
Background: One contributing factor to the development of nocebo effects is information provided about possible side effects. However, non-disclosure of information can be problematic.
Geers, Andrew L, Pearson, Sarah, Colagiuri, Ben, Huynh, Anna, Helfer, Suzanne, Faasse, Kate   +5 more
core   +1 more source

Conspiracies and the nocebo effect during the COVID-19 pandemic. [PDF]

J Public Health (Oxf), 2022
Siguan AA.
europepmc   +1 more source

Introducing the ‘Drucebo’ effect in statin therapy: a systematic review of studies comparing reported rates of statin‐associated muscle symptoms, under blinded and open‐label conditions

Journal of Cachexia, Sarcopenia and Muscle, 2018
Background The ‘placebo effect’ and ‘nocebo effect’ are phenomena whereby beneficial (placebo) or adverse (nocebo) effects result from the expectation that an inert substance will relieve or cause a particular symptom.
Peter E. Penson, G. B. John Mancini, Peter P. Toth, Seth S. Martin, Gerald F. Watts, Amirhossein Sahebkar, Dimitri P. Mikhailidis, Maciej Banach, on behalf of Lipid and Blood Pressure Meta‐Analysis Collaboration (LBPMC) Group & International Lipid Expert Panel (ILEP)   +8 more
doaj   +1 more source

Editorial: The nocebo effect and its consequences for clinical trials and clinical practice. [PDF]

Front Psychol, 2022
Wartolowska K, Colloca L, Amanzio M.
europepmc   +1 more source

FG. The nocebo effect and its relevance for clinical practice. Psychosom Med

, 2020
Negative expectations deriving from the clinical encounter can produce negative outcomes, known as nocebo effects. Specifically, research on the nocebo effect indicates that information disclosure about potential side effects can itself contribute to ...
M.D Luana Colloca, Ph.D Franklin G Miller   +1 more
core  

The role of attention in placebo and nocebo effects

Annals of Behavioral Medicine
Background: Although some existing models propose that attention may be crucially implicated in placebo/nocebo effects, empirical research on this aspect remains limited and scattered. Purpose: This systematic review aims to provide an inclusive overview of studies that have either directly manipulated or assessed attention within the context of ...
Diletta Barbiani, Eleonora M Camerone, Francesca Grosso, Andrew L Geers, Francesco Pagnini   +4 more
openaire   +2 more sources

Did a Nocebo Effect Contribute to the Rise in Special Education Enrollment Following the Flint, Michigan Water Crisis? [PDF]

Clin Psychol Eur, 2023
Roy S, Petrie KJ, Gamble G, Edwards MA.
europepmc   +1 more source

Chicken or egg? Attribution hypothesis and nocebo hypothesis to explain somatization associated to perceived RF-EMF exposure

Frontiers in Public Health
IntroductionThe aim of this study is to understand the temporal relationship between the somatization usually attributed to RF-EMFs, and to evaluate the attribution hypothesis and the nocebo hypothesis in this context.MethodIn this longitudinal study ...
S. Ariccio, E. Traini, L. Portengen, A. Martens, P. Slottje, R. Vermeulen, A. Huss   +6 more
doaj   +1 more source